Cardinal Health price target raised to $148 from $145 at Argus

Argus analyst Kristina Ruggeri raised the firm’s price target on Cardinal Health (CAH) to $148 from $145 and keeps a Buy rating on the shares. The firm is positive on the company’s long-term strategy and progress this past year amid an expanding health care market, the analyst tells investors in a research note. Cardinal’s core Pharmaceutical and Specialty Solutions, which provides more than 90% of its revenues, has seen robust utilization and the onboarding of new customers, which has helped the company to mitigate challenges from loss of a large client in 2023, the firm added.